Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow biopsy samples (n = 5) showed no expression of AQP5, 32% of CML patient samples (n = 41) demonstrated AQP5 expression. In addition, AQP5 expression level increased with the emergence of imatinib mesylate resistance in paired samples (p = 0.047). We have found that the overexpression of AQP5 in K562 cells resulted in increased cell proliferation. In addition, small interfering RNA (siRNA) targeting AQP5 reduced the cell proliferation rate in both K562 and LAMA84 CML cells. Moreover, by immunoblotting and flow cytometry, we show that phosphorylation of BCR-ABL1 is increased in AQP5-overexpressing CML cells and decreased in AQP5 siRNA-treated CML cells. Interestingly, caspase9 activity increased in AQP5 siRNA-treated cells. Finally, FISH showed no evidence of AQP5 gene amplification in CML from bone marrow. In summary, we report for the first time that AQP5 is overexpressed in CML cells and plays a role in promoting cell proliferation and inhibiting apoptosis. Furthermore, our findings may provide the basis for a novel CML therapy targeting AQP5.
References
[1]
King LS, Agre P (1996) Pathophysiology of the aquaporin water channels. Annu Rev Physiol 58: 619.
[2]
Verkman AS, van Hoek AN, Ma T, et al. (1996) Water transport across mammalian cell membranes. Am J Physiol 270: C12–30.
[3]
Gresz V, Kwon TH, Gong H, et al. (2004) Immunolocalization of AQP-5 in rat parotid and submandibular salivary glands after stimulation or inhibition of secretion in vivo. Am J Physiol Gastrointest Liver Physiol 287: G151–61.
[4]
Krane CM, Melvin JE, Nguyen HV, et al. (2001) Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation. J Biol Chem 276: 23413–20.
[5]
Kreda SM, Gynn MC, Fenstermacher DA, Boucher RC, Gabriel SE (2001) Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 24: 224–34.
[6]
Burghardt B, Elkaer ML, Kwon TH, et al. (2003) Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. Gut 52: 1008–1016.
[7]
Dobbs LG, Gonzalez R, Matthay MA, et al. (1998) Highly water-permeable type I alveolar epithelial cells confer high water permeability between the airspace and vasculature in rat lung. Proc Natl Acad Sci U S A 95: 2991–6.
[8]
Saadoun S, Papadopoulos MC, Davies DC, Bell BA, Krishna S (2002) Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer 87: 621–3.
[9]
Moon C, Soria JC, Jang SJ, et al. (2003) Involvement of aquaporins in colorectal carcinogenesis. Oncogene 22: 6699–703.
[10]
Vacca A, Frigeri A, Ribatti D, et al. (2001) Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol 113: 415–21.
[11]
Kageyama Y, Sasaki S, Yamamura Y, Oshima H, Ikawa Y (1996) Water channel protein subtype suggests the origin of renal cell carcinoma. J Urol 156: 291–5.
[12]
Yang J, Shi Y, Cheng Q, Deng L (2006) Expression and localization of aquaporin-5 in the epithelial ovarian tumors. Gynecologic Oncology 100: 294–299.
[13]
Moon C, Rousseau R, Soria JC, et al. (2004) Aquaporin expression in human lymphocytes and dendritic cells. Am J Hematol 75: 128–33.
[14]
Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS (2005) Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 434: 786–92.
[15]
Hoque MO, Soria JC, Woo J, et al. (2006) Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth. Am J Pathol 168: 1345–53.
[16]
Woo J, Lee J, Kim MS, Jang SL, Sidransky D, et al. (2007) The effect of aquaporin 5 overexpression on the Ras signaling pathway. Biochem Biophys Res Commun prepublished on December 26, 2007, as doi:10.1016/j.bbrc.2007.12.073.
[17]
Woo J, Lee J, Chae YK, et al. (2008) Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation. Cancer Lett. In press.
[18]
Kang SK, Chae YK, Woo J, Kim MS, Baek JH, et al. (2008) Role of Human Aquaporin 5 (hAQP5) In Colorectal Carcinogenesis. Am J Pathol. In Press.
[19]
Chae YK, Woo J, Kim M, Kang S, Kim MS, et al. (2008) Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancer. PLoS ONE In press.
[20]
Kang HY, Hwang JY, Kim SH, Goh HG, Kim M, et al. (2006) Comparison of allele specific oligonucleotide-polymerase chain reaction and direct sequencing for high throughput screening of ABL kinase domain mutations in chronic myeloid leukemia resistant to imatinib. Haematologica 91(5): 659–62.
[21]
Litzow MR (2006) Imatinib resistance: obstacles and opportunities. Arch Pathol Lab Med 130(5): 669–79.
[22]
Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, et al. (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18(2): 189–218.
[23]
Kotton DN, Ma BY, Cardoso WV, et al. (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128(24): 5181–8.
[24]
Kotton DN, Fine A (2003) Derivation of lung epithelium from bone marrow cells. Cytotherapy 5(2): 169–73.
[25]
Hoque MO, Soria JC, Woo J, et al. (2006) Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth. Am J Pathol 168: 1345–53.
[26]
Sattler M, Griffin JD (2003) Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin Hematol 40: (2 Suppl 2)4–10.
[27]
Ravandi F, Kantarjian HM, Talpaz M, et al. (2001) Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance. Cancer 91(11): 1964–72.
[28]
Dai Y, Rahmani M, Corey SJ, Dent P, Grant S (2004) A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. J Biol Chem 279(33): 34227–39.
[29]
Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM (2004) Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat Med 10(11): 1187–9.
